Prelude Capital Management’s Enphys Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 NFYS.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-306,250
Closed -$15.3K 1425
2023
Q2
$15.3K Hold
306,250
﹤0.01% 1012
2023
Q1
$36.8K Hold
306,250
﹤0.01% 1024
2022
Q4
$27.6K Hold
306,250
﹤0.01% 1164
2022
Q3
$30K Hold
306,250
﹤0.01% 1253
2022
Q2
$49K Hold
306,250
﹤0.01% 1483
2022
Q1
$86K Buy
+306,250
New +$121K ﹤0.01% 1439

Other funds holding NFYS.WS

Prelude Capital Management's NFYS.WS Position: Q3 2023 in Review

Prelude Capital Management sold out of Enphys Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 (NFYS.WS) in Q3 2023, closing a stake of 306,250 shares — an estimated $15.3K sold.

Prelude Capital Management first reported a position in NFYS.WS in Q1 2022 and held it in 6 quarters. The position peaked at $86K in Q1 2022. 36 funds tracked by Wall St. Rank hold NFYS.WS as of Q3 2023.

  • Prelude Capital Management reported no remaining Enphys Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position as of Q3 2023 after selling out during the quarter.
  • Prelude Capital Management sold 306,250 Enphys Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 shares in Q3 2023, an estimated $15.3K.
  • Prelude Capital Management first reported a position in Enphys Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 in Q1 2022 and held it in 6 quarters.
  • Prelude Capital Management's Enphys Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position peaked at $86K in Q1 2022.
  • 36 funds tracked by Wall St. Rank held Enphys Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 as of Q3 2023.

Based on Prelude Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.